Figure 1. Neuroblastoma Patient Outcomes Based on UBE4B Expression.
A. Using the neuroblastoma Versteeg (top) and SEQC (bottom) patient data-sets in the R2 Genomics Analysis and Visualization Platform (http://r2.amc.nl), patients were divided into high (blue) and low (red) UBE4B gene expression groups by median-centered Log2 ratios and survival curves were generated. Relapse-free survival (top left), event-free survival (bottom left) and overall survival (right) curves are shown with patient numbers in parentheses. B. Relative UBE4B expression levels were plotted in patients with and without relapse from the Versteeg (top) and SEQC (bottom) patient data-sets, with patient numbers shown in parentheses. C. Numbers of patients with high or low UBE4B expression among patients either alive or dead at the time of data censoring for the Versteeg (top) and SEQC (bottom) data-sets.